Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Establishment Labs Holdings Inc. (NASDAQ:ESTA) has received an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $87.1429.

ESTA has been the subject of a number of research analyst reports. Wall Street Zen cut Establishment Labs from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Citigroup reissued a “neutral” rating on shares of Establishment Labs in a research note on Wednesday, May 6th. TD Cowen reaffirmed a “buy” rating on shares of Establishment Labs in a research note on Monday, June 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Establishment Labs in a report on Wednesday, June 24th. Finally, BTIG Research boosted their price target on shares of Establishment Labs from $88.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th.

Establishment Labs Stock Performance

NASDAQ:ESTA opened at $91.12 on Wednesday. Establishment Labs has a fifty-two week low of $33.35 and a fifty-two week high of $92.83. The company has a debt-to-equity ratio of 16.82, a quick ratio of 1.91 and a current ratio of 2.96. The company has a 50 day moving average price of $76.87 and a 200 day moving average price of $71.15. The stock has a market capitalization of $2.68 billion, a P/E ratio of -61.15 and a beta of 1.06.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.45) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.10). Establishment Labs had a negative return on equity of 218.77% and a negative net margin of 19.05%.The firm had revenue of $59.88 million for the quarter, compared to analyst estimates of $57.40 million. During the same quarter last year, the company earned ($0.70) earnings per share. The firm’s revenue for the quarter was up 44.7% on a year-over-year basis. Equities research analysts forecast that Establishment Labs will post -1.07 EPS for the current year.

Insiders Place Their Bets

In other Establishment Labs news, Director Quiros Juan Jose Chacon sold 105,000 shares of the stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total value of $7,919,100.00. Following the sale, the director owned 927,504 shares of the company’s stock, valued at $69,952,351.68. This trade represents a 10.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last quarter, insiders sold 292,500 shares of company stock worth $20,591,021. 9.99% of the stock is owned by corporate insiders.

Institutional Trading of Establishment Labs

A number of large investors have recently made changes to their positions in ESTA. NewEdge Advisors LLC lifted its stake in Establishment Labs by 14.8% in the first quarter. NewEdge Advisors LLC now owns 10,284 shares of the company’s stock worth $584,000 after acquiring an additional 1,327 shares during the last quarter. Bank of America Corp DE increased its position in shares of Establishment Labs by 56.7% in the 1st quarter. Bank of America Corp DE now owns 416,840 shares of the company’s stock valued at $23,668,000 after purchasing an additional 150,797 shares during the last quarter. ADAR1 Capital Management LLC increased its position in shares of Establishment Labs by 24.5% in the 1st quarter. ADAR1 Capital Management LLC now owns 213,473 shares of the company’s stock valued at $12,121,000 after purchasing an additional 42,051 shares during the last quarter. California State Teachers Retirement System raised its holdings in shares of Establishment Labs by 42.3% in the 1st quarter. California State Teachers Retirement System now owns 22,120 shares of the company’s stock valued at $1,256,000 after purchasing an additional 6,579 shares in the last quarter. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of Establishment Labs in the 1st quarter valued at $318,000. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.